ProArc Medical Ltd., is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is to improve the standard of care for patients with Benign Prostatic Hyperplasia (BPH). Our product, ClearRing, designed to treat lower urinary tract symptoms (LUTS) due to BPH.
ProArc Medical was founded in August 2010 through the Misgav Venture Accelerator, funded by the Trendlines Group, a leading Israeli investment and business development firm and private investors.
ProArc Medical leading team includes:
- Mr. Shai Golan as a CEO, with more than 11 years eaperiance of leading multidisciplinary projects both in medical devices and military industries; Shai holds M.Sc., B.Sc. in electrical and computer engineering.
- Dr. Yair Feld, M.D and Ph.D. in physiology and biophysics is the founder. Dr Feld has over 10 years of experience in managing life science companies and R&D projects and founded also GeneGrafts Ltd., CorAssist Cardiovascular, and Nephera;
- Dr. Ilan Leibovitch, M.D, who is the chairman of the Department of Urology in Meir Medical Center in Kfar Saba, Israel serves as the company SAB.